Scarica l'app Stockscreener
0.5911
5.38%
-0.0336
Dopo l'orario di chiusura:
.61
0.0189
+3.20%
Nexgel Inc Borsa (NXGL) Ultime notizie
Exclusive: NexGel to acquire regenerative biomaterial portfolio from Celularity, expects to triple revenue - MSN
Fed Watch: Is NEXGEL Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Shootin' the Bull about "has to" - barchart.com
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Published on: 2026-04-01 05:28:13 - baoquankhu1.vn
NexGel (NXGL) Releases Q4 2025 Earnings: Revenue Down, Losses Narrow, Cash Tight - Quiver Quantitative
NXGL: Revenue up 31.5% to $11.4M, but ongoing losses and liquidity risks persist - TradingView
Nexgel 2025 10-K: Revenues $11.4M, EPS (0.38) - TradingView
NexGel (NASDAQ: NXGL) grows 2025 revenue 31% but warns on going concern - Stock Titan
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
NXGL PE Ratio & Valuation, Is NXGL Overvalued - Intellectia AI
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity - MarketScreener
NEXGEL delays earnings call a week to add detail on Celularity deal - Stock Titan
Trend Report: Should you avoid NEXGEL Inc stock right nowWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn
How does NEXGEL Inc Equity Warrant score in quality rankingsWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn
The Metals Company: Unlocking a Klondike-Quality Mineral Rush - Barchart
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Insider Trends: Is NEXGEL Inc stock technically oversoldWeekly Gains Report & Weekly Market Pulse Updates - baoquankhu1.vn
Johanna Gonzalez Announces TRUE 4G Method - Barchart.com
Published on: 2026-03-28 04:45:25 - baoquankhu1.vn
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
NexGel Inc Stock: Innovative Medical Gels Positioned for Growth in Healthcare and Beauty Markets - AD HOC NEWS
3 Stocks Under $50 That Concern Us - Barchart.com
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com
NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan
Oxford Industries Earnings: What To Look For From OXM - Barchart
NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo
Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Is Cooper Companies Stock Underperforming the Dow? - Barchart.com
Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn
Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo
NexGel (NXGL) Expected to Announce Earnings on Monday - Defense World
NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria
UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com
NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada
OSI Systems (OSIS): 3 Reasons We Love This Stock - Barchart
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks
NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView
Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):